Alector Inc (ALEC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $378.15M
Last updated: Nov 17, 2026 at 11:04 AM ET
Alector Inc (ALEC) Competitors
The companies most similar to Alector are Avalo Therapeutics (AVTX), Galectin Therapeutics (GALT) and Ovid Therapeutics (OVID). By market cap, Alector ranks 8th of the 13 companies on this page; Adlai Nortye Ltd. American Depositary Shares (ANL) is the largest at $683.26M.
Peer Comparison
ALEC's revenue growth of 4896.0% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Alector (ALEC) | $378.15M | 7.3x | 1.7x | 23.9% | N/A | 4896.0% | 0.00% |
| Avalo Therapeutics Inc (AVTX) | $448.71M | N/A | N/A | 0.0% | N/A | -69.3% | 0.00% |
| Galectin Therapeutics Inc (GALT) | $307.59M | N/A | N/A | 0.0% | 671.1% | 0.0% | 0.00% |
| Ovid Therapeutics Inc (OVID) | $479.38M | N/A | 335.8x | 0.0% | N/A | -88.3% | 0.00% |
| Fulcrum Therapeutics Inc (FULC) | $287.96M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Prothena Corporation plc (PRTA) | $419.01M | N/A | 7.8x | -45.4% | N/A | -74.3% | 0.00% |
| Larimar Therapeutics Inc (LRMR) | $313.73M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Neurogene Inc (NGNE) | $495.37M | N/A | N/A | 0.0% | -28.5% | 0.0% | 0.00% |
| Shattuck Labs Inc (STTK) | $473.57M | N/A | N/A | 0.0% | N/A | -66.6% | 0.00% |
| PepGen Ltd (PEPG) | $410.98M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| Arcturus Therapeutics Holdings Inc (ARCT) | $240.96M | N/A | 7.7x | -285.9% | N/A | 6.7% | 0.00% |
| Adlai Nortye Ltd. American Depositary Shares (ANL) | $683.26M | N/A | 8.1x | -124.8% | -7.3% | 178.1% | 0.00% |
| Peer median | $415.00M | N/A | 7.8x | 0.0% | -7.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Alector, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Avalo Therapeutics Inc (AVTX) | Avalo Therapeutics Inc is a forward-thinking clinical-stage biotechnology company focused on developing transformative therapies for rare and underserved... | AVTX competitors |
| Galectin Therapeutics Inc (GALT) | Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic... | GALT competitors |
| Ovid Therapeutics Inc (OVID) | Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. | OVID competitors |
| Fulcrum Therapeutics Inc (FULC) | Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined... | FULC competitors |
| Prothena Corporation plc (PRTA) | Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases... | PRTA competitors |
| Larimar Therapeutics Inc (LRMR) | Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. | LRMR competitors |
| Neurogene Inc (NGNE) | Neurogene Inc. is an innovative biotechnology company at the forefront of developing advanced gene therapies for rare neurological disorders... | NGNE competitors |
| Shattuck Labs Inc (STTK) | Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. | STTK competitors |
| PepGen Ltd (PEPG) | PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious... | PEPG competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
| Arcturus Therapeutics Holdings Inc (ARCT) | Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. | ARCT competitors |
| Adlai Nortye Ltd. American Depositary Shares (ANL) | Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. |
Frequently Asked Questions About ALEC
Who are Alector's main competitors?
The companies most similar to Alector include Avalo Therapeutics (AVTX), Galectin Therapeutics (GALT), Ovid Therapeutics (OVID), Fulcrum Therapeutics (FULC) and Prothena Corporation (PRTA), listed from the closest match.
Who is Alector's biggest competitor?
Adlai Nortye Ltd. American Depositary Shares (ANL) is the largest of the similar companies at $683.26M; Avalo Therapeutics (AVTX) is the closest match by business profile, size, sector and industry.
How does ALEC stock compare with its competitors?
ALEC's P/S is 1.7x against a peer median of 7.8x; its net margin is 23.9% against a peer median of 0.0%.
Which of Alector's competitors pays a higher dividend?
Alector pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Alector bigger than its competitors?
No. Alector is 8th by market cap among the 13 companies on this page; the largest is Adlai Nortye Ltd. American Depositary Shares (ANL) at $683.26M.
ALEC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors